Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trialChristoph A. Fink, Stefan A. Koerber, Carolin Buchele et al.|Clinical and Translational Radiation Oncology|2024Cited by 4